Labeling changes have been approved for erectile dysfunction drugs such as Generic Cialis, Generic Levitra, and Generic Viagra, to display the potential risk of sudden hearing loss in a more prominent fashion. The FDA plans to require the same changes for Revatio, which is used to treat pulmonary arterial hypertension (PAH).
The FDA asked for the label revisions after a small number of patients taking these drugs reported sudden hearing loss, sometimes accompanied by ringing in the ears and dizziness.
Patients taking Cialis drug, Levitra drug, or Viagra drug who experience sudden hearing loss should immediately stop taking the drug and should seek prompt medical attention.


What you should know about Botox injection to stop your sweating problems